Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Advertising

Press Release

Global Preclinical Stage Partnering Terms and Agreements in Pharma and Biotech 2010-2017 - Research and Markets

Research and Markets
Posted on: 25 Aug 17

The "Global Preclinical Stage Partnering Terms and Agreements in Pharma and Biotech 2010-2017" report has been added to Research and Markets' offering.

The Global Preclinical Stage Partnering Terms and Agreements in Pharma and Biotech 2010-2017 report provides a detailed understanding and analysis of how, why and what terms companies enter preclinical stage partnering deals. These deals tend to be multicomponent, starting with collaborative R&D, and commercialization of outcomes.

This report provides details of the latest preclinical agreements announced in the healthcare sector.

This report contains a comprehensive listing of over 2,000 preclinical stage partnering deals announced since 2010 including financial terms, where available, including links to online deal records of actual preclinical partnering deals as disclosed by the deal parties. In addition, where available, records include contract documents as submitted to the Securities Exchange Commission by companies and their partners.

Report scope:

  • Trends in preclinical stage dealmaking in the biopharma industry since 2010
  • Analysis of preclinical stage deal structure
  • Access to headline, upfront, milestone and royalty data
  • Case studies of real-life preclinical stage deals
  • Access to over 2,000 preclinical stage deals
  • The leading preclinical stage deals by value since 2010
  • Most active preclinical stage dealmakers since 2010
  • The leading preclinical stage partnering resources

Available contracts are listed by:

  • Company A-Z
  • Headline value
  • Stage of development at signing
  • Deal type
  • Specific therapy target

Key Topics Covered:

Executive Summary

Chapter 1 - Introduction

Chapter 2 - Why do companies partner preclinical stage compounds?

Chapter 3 - Preclinical stage deal strategies and structure

Chapter 4 - Preclinical stage partnering payment strategies

Chapter 5 - Trends in preclinical stage deal making

Chapter 6 - Payment terms for preclinical stage partnering

Chapter 7 - Leading preclinical stage deals

Chapter 8 - Top 50 most active preclinical stage dealmakers

Chapter 9 - Preclinical stage partnering contracts directory

Chapter 10 - Preclinical stage deal making by development stage

For more information about this report visit https://www.researchandmarkets.com/research/lk9lld/global

View source version on businesswire.com: http://www.businesswire.com/news/home/20170825005168/en/

Business Wire
www.businesswire.com

Last updated on: 25/08/2017

Advertising
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.